Cargando…

Severe Asthma in the Era of Biologics: Continuous Challenges

Detalles Bibliográficos
Autores principales:	Schoini, Pinelopi, Bakakos, Petros, Loukides, Stelios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253601/ https://www.ncbi.nlm.nih.gov/pubmed/37298052 http://dx.doi.org/10.3390/jcm12113857

Ejemplares similares

Severe Eosinophilic Asthma
por: Bakakos, Agamemnon, et al.
Publicado: (2019)

Severe asthma: anti-IgE or anti-IL-5?
por: Papathanassiou, Evgenia, et al.
Publicado: (2016)

Exploring Mechanisms in COPD: Time for Biomarker Reappraisal?
por: Voulgareli, Ilektra, et al.
Publicado: (2023)

Identification of asthma phenotypes using blood cell count
por: Papaioannou, Andriana I, et al.
Publicado: (2022)

An algorithmic approach for the treatment of severe uncontrolled asthma
por: Zervas, Eleftherios, et al.
Publicado: (2018)

Primary care and COVID-19: cutting the Gordian knot – the Greek experience and algorithm
por: Tomos, Ioannis, et al.
Publicado: (2020)

Reducing Tolerance for SABA and OCS towards the Extreme Ends of Asthma Severity
por: Bakakos, Petros, et al.
Publicado: (2022)

Biological Therapy of Severe Asthma and Nasal Polyps
por: Bakakos, Agamemnon, et al.
Publicado: (2022)

Direct and Indirect Costs of Asthma Management in Greece: An Expert Panel Approach
por: Souliotis, Kyriakos, et al.
Publicado: (2017)

Asthma: From Phenotypes to Personalized Medicine
por: Bakakos, Petros
Publicado: (2022)

Sirtuin 1: Endocan and Sestrin 2 in Different Biological Samples in Patients with Asthma. Does Severity Make the Difference?
por: Tsilogianni, Zoe, et al.
Publicado: (2020)

Implication of IL-18 in chronic inflammation of severe refractory asthma
por: Rovina, Nikoletta, et al.
Publicado: (2015)

New insights into the pathophysiology and therapeutic targets of asthma and comorbid chronic rhinosinusitis with or without nasal polyposis
por: Striz, Ilja, et al.
Publicado: (2023)

Treatment Challenges in Severe Eosinophilic Asthma: Differential Response to Anti-IL-5 and Anti-IL-5R Therapy
por: Bakakos, Agamemnon, et al.
Publicado: (2021)

Depression Levels Influence the Rate of Asthma Exacerbations in Females
por: Anastasia, Papaporfyriou, et al.
Publicado: (2021)

Sputum interleukin (IL)-13 as a biomarker for the evaluation of asthma control
por: Tsilogianni, Zoi, et al.
Publicado: (2015)

Dual Bronchodilator in the Era of Triple Therapy
por: Papaioannou, Andriana I, et al.
Publicado: (2020)

IL-26 in the Lung and Its Role in COPD Inflammation
por: Bartziokas, Konstantinos, et al.
Publicado: (2022)

Exhaled breath condensate pH as a biomarker of COPD severity in ex-smokers
por: Papaioannou, Andriana I, et al.
Publicado: (2011)

Unraveling the Relationship of Asthma and COVID-19
por: Bakakos, Agamemnon, et al.
Publicado: (2021)

Increased Red Cell Distribution Width Is Associated With Disease Severity in Hospitalized Adults With SARS-CoV-2 Infection: An Observational Multicentric Study
por: Karampitsakos, Theodoros, et al.
Publicado: (2020)

SARS-Cov-2 Infection in Severe Asthma Patients Treated With Biologics
por: Papaioannou, Andriana I., et al.
Publicado: (2022)

Cardiovascular Diseases in COPD: From Diagnosis and Prevalence to Therapy
por: Papaporfyriou, Anastasia, et al.
Publicado: (2023)

Nonadherence in the era of severe asthma biologics and thermoplasty
por: Lee, Joy, et al.
Publicado: (2018)

Characterisation of patients with severe asthma in the UK Severe Asthma Registry in the biologic era
por: Jackson, David J, et al.
Publicado: (2021)

Epidemiology and Immunopathogenesis of Virus Associated Asthma Exacerbations
por: Bakakos, Agamemnon, et al.
Publicado: (2023)

Fever and multilobular mass of the right lung in a young adult with asthma
por: Sotiriou, Adamantia, et al.
Publicado: (2015)

Sestrin 2 levels are associated with emphysematous phenotype of COPD
por: Angelakis, Leonidas, et al.
Publicado: (2022)

Extrafine Beclometasone Dipropionate/Formoterol NEXThaler on Device Usability, Adherence, Asthma Control and Quality of Life. A Panhellenic Prospective, Non-Interventional Observational Study in Patients with Asthma—The NEXT-Step Study
por: Bakakos, Petros, et al.
Publicado: (2022)

Severe T2-high asthma in the biologics era: European experts' opinion
por: Pavord, Ian, et al.
Publicado: (2019)

Patients Hospitalized for COVID-19 in the Periods of Delta and Omicron Variant Dominance in Greece: Determinants of Severity and Mortality
por: Karageorgou, Vagia, et al.
Publicado: (2023)

Biologic Targeting: New and Effective Therapeutic Approaches against Severe Asthma
por: Yang, Xin, et al.
Publicado: (2018)

Epigenetics of asthma—the field continues to evolve
por: Rastogi, Deepa
Publicado: (2022)

The challenge continues
Publicado: (2018)

The continuity of a new era in the AE&M
Publicado: (2023)

Biological therapy for severe asthma – Indian perspectives and challenges
por: Venkitakrishnan, Rajesh, et al.
Publicado: (2023)

Reflecting on World Asthma Day in the era of COVID-19
por: The Lancet Respiratory Medicine
Publicado: (2020)

Intermittent to Mild Asthma: The Need for Continued Treatment
por: Yoon, Ho Joo
Publicado: (2013)

Asthma in the Precision Medicine Era: Biologics and Probiotics
por: Chiu, Chiao-Juno, et al.
Publicado: (2021)

Challenges and opportunity in the era of quantitative echocardiography
por: Yu, Cheuk-Man
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_loh5alh3uakaoa01gilvjubq4g